Search research articles
Contact Us
Filters
Showing results (271-280 of 1,278) with videos related to
Page
of 128
Sort By:
Proteins
|
November 19, 2011
The dual role of fragments in fragment-assembly methods for de novo protein structure prediction
Julia Handl, Joshua Knowles, Robert Vernon, et al.
Brain Pathology (Zurich, Switzerland)
|
April 13, 2017
Axonal loss in the multiple sclerosis spinal cord revisited
Natalia Petrova, Daniele Carassiti, Daniel R Altmann, et al.
Multiple Sclerosis and Related Disorders
|
April 17, 2015
The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis
David Baker, Gareth Pryce, Samuel J Jackson, et al.
Biorxiv : the Preprint Server for Biology
|
October 24, 2023
Single-cell signaling analysis reveals that Major Vault Protein facilitates RasG12C inhibitor resistance
Jason Z Zhang, Shao-En Ong, David Baker, et al.
Multiple Sclerosis and Related Disorders
|
June 17, 2017
Depletion of CD20 B cells fails to inhibit relapsing mouse experimental autoimmune encephalomyelitis
Eseberuo Sefia, Gareth Pryce, Ute-Christiane Meier, et al.
Protein Science : a Publication of the Protein Society
|
September 11, 2023
Zero-shot mutation effect prediction on protein stability and function using RoseTTAFold
Sanaa Mansoor, Minkyung Baek, David Juergens, et al.
Proteins
|
July 29, 2021
Protein oligomer modeling guided by predicted interchain contacts in CASP14
Minkyung Baek, Ivan Anishchenko, Hahnbeom Park, et al.
Molecular Systems Design & Engineering
|
March 10, 2022
Parallelized identification of on- and off-target protein interactions
Jiayi Dou, Inna Goreshnik, Cassie Bryan, et al.
Multiple Sclerosis and Related Disorders
|
May 29, 2020
The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic
David Baker, Sandra Amor, Angray S Kang, et al.
Multiple Sclerosis and Related Disorders
|
July 7, 2019
Plasma cell and B cell-targeted treatments for use in advanced multiple sclerosis
David Baker, Benjamin M Jacobs, Sharmilee Gnanapavan, et al.
Page
of 128
Search research articles
Search
Showing results (271-280 of 1,278) with videos related to
Sort By:
Page
of 128
Proteins
|
November 19, 2011
The dual role of fragments in fragment-assembly methods for de novo protein structure prediction
Julia Handl, Joshua Knowles, Robert Vernon, et al.
Brain Pathology (Zurich, Switzerland)
|
April 13, 2017
Axonal loss in the multiple sclerosis spinal cord revisited
Natalia Petrova, Daniele Carassiti, Daniel R Altmann, et al.
Multiple Sclerosis and Related Disorders
|
April 17, 2015
The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis
David Baker, Gareth Pryce, Samuel J Jackson, et al.
Biorxiv : the Preprint Server for Biology
|
October 24, 2023
Single-cell signaling analysis reveals that Major Vault Protein facilitates RasG12C inhibitor resistance
Jason Z Zhang, Shao-En Ong, David Baker, et al.
Multiple Sclerosis and Related Disorders
|
June 17, 2017
Depletion of CD20 B cells fails to inhibit relapsing mouse experimental autoimmune encephalomyelitis
Eseberuo Sefia, Gareth Pryce, Ute-Christiane Meier, et al.
Protein Science : a Publication of the Protein Society
|
September 11, 2023
Zero-shot mutation effect prediction on protein stability and function using RoseTTAFold
Sanaa Mansoor, Minkyung Baek, David Juergens, et al.
Proteins
|
July 29, 2021
Protein oligomer modeling guided by predicted interchain contacts in CASP14
Minkyung Baek, Ivan Anishchenko, Hahnbeom Park, et al.
Molecular Systems Design & Engineering
|
March 10, 2022
Parallelized identification of on- and off-target protein interactions
Jiayi Dou, Inna Goreshnik, Cassie Bryan, et al.
Multiple Sclerosis and Related Disorders
|
May 29, 2020
The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic
David Baker, Sandra Amor, Angray S Kang, et al.
Multiple Sclerosis and Related Disorders
|
July 7, 2019
Plasma cell and B cell-targeted treatments for use in advanced multiple sclerosis
David Baker, Benjamin M Jacobs, Sharmilee Gnanapavan, et al.
Page
of 128